Sodium-Glucose Cotransporter 2 Inhibitor–induced Ketoacidosis and Non-Ketotic Acidosis: When Is There a Role for Bicarbonate?
- 1 June 2023
- journal article
- editorial
- Published by Oxford University Press (OUP) in Annals of the American Thoracic Society
- Vol. 20 (6) , 911-916
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic controlNature Reviews Cardiology, 2020
- Molecular Pathophysiology of Acid-Base DisordersSeminars in Nephrology, 2019
- Ketoacidosis associated with SGLT2 inhibitor treatment: Analysis of FAERS dataDiabetes/Metabolism Research and Reviews, 2017
- Review of Evidence for Adult Diabetic Ketoacidosis Management ProtocolsFrontiers in Endocrinology, 2017
- Renal Handling of Ketones in Response to Sodium–Glucose Cotransporter 2 Inhibition in Patients With Type 2 DiabetesDiabetes Care, 2017
- Ketosis and diabetic ketoacidosis in response to SGLT2 inhibitors: Basic mechanisms and therapeutic perspectivesDiabetes/Metabolism Research and Reviews, 2017
- SGLT2 selective inhibitor ipragliflozin reduces body fat mass by increasing fatty acid oxidation in high-fat diet-induced obese ratsEuropean Journal of Pharmacology, 2014
- Treatment of acute metabolic acidosis: a pathophysiologic approachNature Reviews Nephrology, 2012
- Role of NH3and NH4+transporters in renal acid-base transportAmerican Journal of Physiology-Renal Physiology, 2011
- Plasma Acid-Base Patterns in Diabetic KetoacidosisNew England Journal of Medicine, 1982